1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
CAMPATH-1 antibodies have a long and successful history in the treatment of leukaemia, autoimmune disease and transplant rejection. The first antibody to undergo "humanisation", CAMPATH-1H, permits treatment with limited patient anti-globulin response. It recognises the CD52 antigen which...
Asıl Yazarlar: | James, L, Hale, G, Waldmann, H, Bloomer, A, Waldman, H |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1999
|
Benzer Materyaller
-
Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
Yazar:: Cheetham, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998) -
Specificity of monoclonal antibody Campath-1.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1988) -
The CAMPATH-1 antigen (CDw52).
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1990) -
Availability of Campath-1 antibodies for bone marrow transplantation.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1995) -
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1994)